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Introduction. Periodic limb movements during sleep (PLMs) is common in the elderly. When quality-of-life drops due to sleep
disturbances, we speak about periodic limb movement disorder during sleep (PLMD). Another similar disorder, restless legs
syndrome (RLS), is considered to be related to diabetes; RLS and PLMDs are genetically related. Our aim was to detect PLMDs in
a population of diabetic patients and identify them as possible hallmarks of these autonomic disorders. Material and Methods.W e
selected 41 type-2 diabetics with no sleep comorbidity, and compared them with 38 healthy matched volunteers. All participants
underwent the Epworth Sleepiness Scale (ESS) and polysomnography (PSG). A periodic limb movement (PLM) index >5, that
is, the higher number of PLMs/sleep hour for the entire night, was considered as abnormal. Results. Diabetics showed lower
sleep eﬃciency than controls on the ESS, lower proportions of REM and non-REM sleep, and higher arousal and PLM indexes,
as assessed through PSG. PLMDs were diagnosed in 13 of 41 diabetic patients (31%); the latter showed lower sleep eﬃciency,
lower non-REM slow-wave sleep, and increased arousal and PLM indexes. Conclusion. The relationship between PLMs-related
sleep fragmentation and endocrine carbohydrate metabolism regulation might be casual or genetically determined. This deserves
further investigations.
1.Introduction
Until recently, it was believed that sleep was important
primarily for restoring brain functions. However, there is
increasing evidence that sleep also modulates the metabolic,
endocrine and cardiovascular systems [1]. Diabetes is pre-
dicted to aﬀect 221 million people worldwide by the end of
2010; this would amount to a 46% increase from 2000 [2]. In
industrialized countries, chronic sleep loss is rapidly increas-
ing along with diabetes, and already aﬀects about 45% of all
adults [3]. Furthermore, alterations in the control of blood
sugar may gradually lead to serious dysregulation of sleep
control and vice versa. In fact, quite intriguingly, a dramatic
increase in the incidence of diabetes and obesity appears to
develop simultaneously with decreased self-reported sleep
duration; this may indicate a close relationship between
diabetes and sleep disorder [4, 5]. In fact, data from the
Sleep Heart Health Study showed that people with diabetes
had less time spent on REM sleep and more breathing
episodesthanpeoplewithoutdiabetes[6].Intype2diabetes,
sleep disturbances are believed to be common and have
been attributed to impaired glucose metabolism and general
physical distress [7]. An association between diabetes and
restless legs syndrome (RLS) has also been reported [8–10],
but other investigations did not conﬁrm the evidence [11].
RLS is characterized by (a) a drive to move the legs often,
accompanied by abnormal leg sensations, (b) symptom
worsening at rest, that is, sitting, (c) partial or temporary
relief by activity, at least as long as the activity continues,
and (d) worsening of the symptoms later in the day or night
[12].The vast majority (90%) of patients have stereotyped
repetitive dorsiﬂexions of the big toe and foot once asleep,
a condition known as periodic limb movements during
sleep (PLMs) [13, 14]. Although RLS and PLMs can occur2 ISRN Endocrinology
independently,theirfrequentassociationsuggestsacommon
etiology.Thishasbeenconﬁrmedrecentlybythediscoveryof
a common gene variant (BTBD9) that confers susceptibility
to both PLMs and RLS [15, 16]. It has been shown that the
prevalence of PLMs is correlated with age; it is found in 5%
of normal subjects aged between 30 and 50 years, in 29% of
subjects over 50 years and in 44% of subjects aged 65 and
older [17]. PLMs have been linked to sleep fragmentation
[18] and corre1ated with impaired subjective sleep quality
[19]. Various polysomnographic studies indicate that PLMs
are often associated with electroencephalographic arousal
[20–23] or with phase A of the cyclic alternating pattern
[24], suggesting a disruption of sleep continuity. When
PLMs cause disturbed sleep, inducing insomnia or daytime
sleepiness, a periodic limb movement disorder during sleep
(PLMDs) is diagnosed [25]. We aimed at investigating the
presence of sleep disturbance due to PLMs in a cohort of
diabetes type 2 patients.
2. Patientsand Methods
A group of 45 consecutive patients with type 2 dia-
betes were compared with 38 healthy, age-, sex-, and
body-mass index (BMI-) matched volunteers (Table l).
The study was approved by the hospital’s medical ethics
committee, and informed consent was obtained from all
participants. Exclusion criteria comprised neurologic or
psychiatric disorders, tobacco, alcohol or drug abuse, history
of sleep apnea syndrome or obesity, chronic renal failure
or uremia, polyneuropathy, rheumatoid arthritis, anemia,
hypothyroidism, chronic obstructive pulmonary disease,
heart disease, liver cirrhosis, and B12 deﬁciency. All the
study participants, before polysomnography (PSG) were
asked to identify the most likely factors contributing to
sleep complaints and ﬁlled-out the Epworth Sleepiness Scale
(ESS) [26]. The ESS is an 8-item self-rated questionnaire
measuring the general level of daytime sleepiness, each
rated according to a 0–3 Likert scale. It can vary from
0 to 24; the “clinically” normal range of the ESS score
is 0 to 10 with a normal statistical distribution; scores
of 11-12 are borderline, and higher scores are probably
pathological, needing expert consultation. PSG is the study
of sleep by means of the electroencephalogram (EEG),
electro-oculogram (EOG), electrocardiogram (ECG), and
submental and tibial electromyograms (EMG). In addition,
recordings involve the measurement of oxygen saturation,
nasal and oral airﬂow, and thoracic and abdominal respi-
ratory movements [27]. The PSG was performed in our
sleep laboratory, a sound-attenuated room with temper-
ature control, using a computer-assisted device (Alice 3;
Healthdyne, Marietta OH). EEG, EOG, ECG, and EMG were
recorded with surface electrodes using standard techniques
[27]. Airﬂow and ventilatory eﬀorts were recorded through
nasal oral thermocouples and thoracic and abdominal belts
with inbuilt piezoelectrodes, respectively. Oxyhemoglobin
saturation was recorded by ﬁnger pulse oximetry (Pu1sox-
7 MinoIta, Osaka, Japan). The transducers and lead wires
allowed normal position changes during sleep. To qualify as
PLMs, leg movements had to last 0.5–10sec, to recur every
5t o9 0 s e c ,a n dt oo c c u ri nas e r i e so fa tl e a s tf o u rs u c h
movements in a row that are at least 8µVi na m p l i t u d e
[27]; periodic movements with close temporal relation to
apnoea or hypopnoea were not interpreted as PLMs. A
PLMs index (numbers of PLMs per hour of sleep) greater
than 5 for the entire night of sleep was considered to be
pathological. Criteria for a diagnosis of PLMDs included a
PLM index of at least 20 per hour and the presence of either
excessive daytime sleepiness (ESS score > 6) and a subjective
feeling of non-restorative or disturbed sleep [24]. Arousals
were scored according to the American Academy of Sleep
Medicine criteria [27]. Bedtime and awakening time were
at each participant’s discretion and the PSG was terminated
after ﬁnal awakenings. To avoid the ﬁrst night eﬀect each
subject spent 2 nights in the sleep laboratory. Only data
recorded during the second night were evaluated.
3.StatisticalAnalysis
Data were reported as means and standard deviations. Sta-
tistical analysis of the anthropometric data and polysomno-
graphic recordings was performed using unpaired Student’s
t-test. Pearson’s Chi-square goodness of ﬁt was used for
other comparisons of means and proportion. The Mann-
Whitney U-test and Spearman’s rank correlation were used
as appropriate. The level of signiﬁcance was set at P<0.05.
All statistical analyses were performed using the statistical
package SPSSV 6.l (SPSS, Inc., Chicago, IL).
4. Results
Four out of 45 patients (9%) were excluded from the study
because they were aﬀected by the sleep apnea syndrome
(Apnea-Hypopnea index at least 10 per hour). Table 1
shows the anthropometric data of patients with type 2
Diabetes and healthy controls, and the most common sleep
complaints, that is, nocturnal awakening (62%), chronic
poor sleep (48%) and sleepiness (50%) (P<0.01 versus
controls). Moreover patients with diabetes scored higher
on the ESS, compared to controls (P<0.05). The sleep
values (Table 2) show that patients with diabetes had lower
sleep eﬃciency (sleep time/time in bed) than controls (P<
0.01); the percentage of REM sleep and non-REM slow wave
sleep were signiﬁcantly lower in diabetics patients (P<
0.01); arousal index and periodic limb movement index
were signiﬁcantly greater in diabetic patients (P<0.01).
A signiﬁcant correlation with the periodic limb movement
index was documented for sleep eﬃciency, arousal index and
ESS score (r =− 0.56; P<0.01; r = 0.78; P< 0.01; r = 0.93;
P<0.001, resp.; Table 3). In 13 of 41 diabetic patients (31%)
PLMDs was diagnosed; in these patients sleep eﬃciency and
non-REM slow wave sleep were signiﬁcantly lower (P<
0.1) and both arousal and periodic limb movement indexes
were signiﬁcantly increased (P<0.01) compared to diabetic
patients without PLMDs (Table 4).ISRN Endocrinology 3
Table 1: Demographic and clinical data in 41 type II diabetes patients and 38 healthy controls.
Type II diabetes patients Healthy controls P
Age, yrs 63 ±46 1 ±5n s
Sex F/M 23/18 21/17 ns
BMI, Kg/m2 27 ±32 6 ±5n s
ESS score 10 ±24 ±20 . 0 5
Chronically poor sleep % 48 15 0.01
Nocturnal awakening % 62 20 0.01
Sleepiness (somnolence) % 50 8 0.01
Data presented as mean ± SD, level of signiﬁcance P<0.05.
BMI: body mass index; ESS: Epworth Sleepiness Scale; ns: not signiﬁcant, F: female; M: male.
Table 2: Sleep values in 41 type II diabetes patients and 38 healthy controls.
Type II diabetes patients Healthy controls P
Sleep time, min 307 ±54 398 ±41 0.001
Sleep eﬃciency, % 77 ±10 89 ±60 . 0 1
nREM stage 1, % sleep time 14 ±51 3 ±5n s
nREM stage 2, % sleep time 42 ±74 0 ±8n s
nREM slow wave, % sleep time 13 ±42 1 ±60 . 0 1
REM, % sleep time 9 ±41 5 ±30 . 0 1
AHI, n/h 3 ±23 ±1n s
Arousal index, n/h 14 ±65 ±10 . 0 1
PLM Index, n/h 22 ±95 ±1 0.001
Data presented as mean ± SD, level of signiﬁcance P<0.05.
REM: rapid eye movements, AHI: apnea hypopnea index, PLM: periodic limb movement.
Table 3: Spearman’s rank correlation (r) between periodic limb
movement index, and sleep functional data and Epworth Sleepiness
Scale score.
Periodic limb movement index versus rP
Sleep eﬃciency −0.56 0.0001
ESS score 0.93 0.0001
Total sleep time −0.67 0.01
Arousal index 0.78 0.0001
Level of signiﬁcance P<0.05.
Table 4: Comparison of sleep-related data in 13 type 2 diabetes
patients subdivided according to the presence of periodic limb
movement disorder during sleep (PLMDs).
PLMDs Yes, n = 13 No, n = 28 P
Sleep eﬃciency, % 71 ±68 3 ±40 . 0 1
Non-REM slow wave,
%s l e e pt i m e 8 ±51 5 ±40 . 0 1
A r o u s a lI n d e x ,n / h 1 7±49 ±30 . 0 1
PLM Index, n/h 28 ±71 5 ±80 . 0 1
Data presented as mean ± SD; level of signiﬁcance P<0.05.
The parameters reported are only those which showed a statistically
signiﬁcant intergroup diﬀerence.
5. Discussion
A large proportion of our diabetes patients reported having
poor sleep quality; in particular the prevalence of PLMs,
in our population of type II diabetes patients is greater
(85%) in comparison with the general populations of
the same age (44%). These ﬁndings were consistent with
previous studies [9]. The nonrestorative sleep of these
patients cannot be directly related to a speciﬁc disruption
of sleep architecture; however, the diabetes type 2 patients
are more easily identiﬁed because they have pathological
PLMs indexes. Indeed, sleep fragmentation linked to PLMs
causes daytime sleepiness. The analysis of the subgroups of
diabetes patients with PLMDs, as shown in Table 4, showed
a marked disruption of sleep architecture, a greater arousal
index, and higher ESS score with respect to diabetes patients
with only PLMs; we consider this as the most important
ﬁnding of this study. In fact, suﬃcient evidence about
bidirectional interactions between sleep, and the endocrine
system exists currently; several hormones have the capacity
to aﬀect sleep and sleep is a key factor in physiological
restoration, with far-reaching medical implications. There-
fore, although the primary function of sleep may be cerebral
restoration, insuﬃcient sleep has consequences also for
peripheral function, that if maintained chronically, could
impact endocrine regulation of carbohydrate metabolism,
including decreased insulin sensitivity [5]. A partial sleep
deprivation (4 hours per night for 6 consecutive nights) may
trigger impaired glucose tolerance, higher evening secretion
of cortisol, increased sympathetic nervous system activity,
and reduced leptin (the appetite suppressant) secretion
[28] and might produce a prediabetic state [5]. Guggisberg
et al. [25] suggest an important role of the sympathetic4 ISRN Endocrinology
system in the generation of PLMs that we can try to
incorporate in this model. A sympathetic activation occurs
periodically in the setting of the physiologic sleep-wake
control; once overcoming a certain threshold, it triggers
or facilitates PLMs. Thus, the magnitude and frequency of
movements would depend on the magnitude and frequency
of the sympathetic oscillation. Previous clinical drug trials
have suggested an involvement of the sympathetic nervous
system, that is, also involved in the generation of sensory
discomfort (i.e., increased vascular tone and decreased blood
ﬂow to the extremities), which accompanies PLMs [29].
Previous studies speculated that potentially dysfunctional
extrapyramidal motor networks are periodically activated
by sympathetic projections and, thus, induce PLMs [30].
In patients with dysfunctional extrapyramidal system due
to Parkinson syndrome [31], normal ﬂuctuations in sym-
pathetic activity might be suﬃcient to trigger PLMs, the
autonomic nervous system being merely responsible for the
periodicity of themovements. Gallegoet al.[32]showed that
the dopamine content of diabetic rats was reduced in several
areas of the central nervous system, including striatum and
midbrain. Based on these considerations, Merlino et al. [33]
suggested that RLS in patients aﬀected by type 2 diabetes
could be due to the coexistence of decreased dopaminergic
control and increased excitatory nociceptive input, the latter
due to peripheral neuropathy and both PLNs and RLS
involved in the pathogenesis dopaminergic deﬁcit.
6. Conclusion
It could be important to detect PLMDs in type 2 diabetes
patients, because poor sleep decreases glucose tolerance and
insulin sensitivity, further worsening the clinical picture of
diabetes and conferring resistance to treatment. Adequately
treating PLMs could normalize sleep architecture and eﬃ-
ciency, improving both quality of life and the control of the
diabetic condition.
References
[ 1 ]M .I .T r e n e l l ,N .S .M a r s h a l l ,a n dN .L .R o g e r s ,“ S l e e p
and metabolic control: waking to a problem?” Clinical and
Experimental Pharmacology and Physiology, vol. 34, no. 1-2,
pp. 1–9, 2007.
[2] A. F. Amos, D. J. McCarty, and P. Zimmet, “The rising
global burden of diabetes and its complications: estimates and
projections to the year 2010,” Diabetic Medicine, vol. 14, no.
12, supplement 5, pp. S7–S85, 1997.
[3] M. H. Bonnet and D. L. Arand, “We are chronically sleep
deprived,” Sleep, vol. 18, no. 10, pp. 908–911, 1995.
[4] K. Spiegel, K. Knutson, R. Leproult, E. Tasali, and E. Van
Cauter, “Sleep loss: a novel risk factor for insulin resistance
and Type 2 diabetes,” Journal of Applied Physiology, vol. 99, no.
5, pp. 2008–2019, 2005.
[ 5 ]E .V a nC a u t e r ,K .S .P o l o n s k y ,a n dA .J .S c h e e n ,“ R o l e so f
circadian rhythmicity and sleep in human glucose regulation,”
Endocrine Reviews, vol. 18, no. 5, pp. 716–738, 1997.
[6] H. E. Resnick, S. Redline, E. Shahar et al., “Diabetes and sleep
disturbances: ﬁndings from the Sleep Heart Health Study,”
Diabetes Care, vol. 26, no. 3, pp. 702–709, 2003.
[7] S. Keinanen-Kiukaanniemi, A. Ohinmaa, H. Pajunp¨ a¨ a, and
P. Koivukangas, “Health related quality of life in diabetic
patientsmeasuredbytheNottinghamHealthProﬁle,”Diabetic
Medicine, vol. 13, no. 4, pp. 382–388, 1996.
[8] S.B.Rutkove,J.K.Matheson,andE.L.Logigian,“Restlesslegs
syndromeinpatientswithpolyneuropathy,”Muscle and Nerve,
vol. 19, no. 5, pp. 670–672, 1996.
[9] L. A. Lopes, C. D. Lins, V. G. Adeodato et al., “Restless legs
syndrome and quality of sleep in type 2 diabetes,” Diabetes
Care, vol. 28, no. 11, pp. 2633–2636, 2005.
[10] F. Gemignani and F. Brindani, “Restless legs syndrome
associated with peripheral neuropathy,” European Journal of
Neurology, vol. 14, no. 7, pp. e9–e10, 2007.
[ 1 1 ]R .P .S k o m r o ,S .L u d w i g ,E .S a l a m o n ,a n dM .H .K r y g e r ,
“Sleep complaints and restless legs syndrome in adult type 2
diabetics,” Sleep Medicine, vol. 2, no. 5, pp. 417–422, 2001.
[12] R. P. Allen, D. Picchietti, W. A. Hening et al., “Restless legs
syndrome: diagnostic criteria, special considerations, and epi-
demiology. A report from the restless legs syndrome diagnosis
and epidemiology workshop at the National Institutes of
Health,” Sleep Medicine, vol. 4, no. 2, pp. 101–119, 2003.
[13] M. Zucconi, R. Ferri, R. Allen et al., “The oﬃcial World Asso-
ciation of Sleep Medicine (WASM) standards for recording
and scoring periodic leg movements in sleep (PLMS) and
wakefulness (PLMW) developed in collaboration with a task
force from the International Restless Legs Syndrome Study
Group (IRLSSG),” Sleep Medicine, vol. 7, no. 2, pp. 175–183,
2006.
[ 1 4 ]L .M .T r o t t i ,D .L .B l i w i s e ,S .A .G r e e re ta l . ,“ C o r r e l a t e so f
PLMs variability over multiple nights and impact upon RLS
diagnosis,” Sleep Medicine, vol. 10, no. 6, pp. 668–671, 2009.
[15] H. Stefansson, D. B. Rye, A. Hicks et al., “A genetic risk factor
for periodic limb movements in sleep,” The New England
Journal of Medicine, vol. 357, no. 7, pp. 639–647, 2007.
[16] J. Winkelmann, B. Schormair, P. Lichtner et al., “Genome-
wide association study of restless legs syndrome identiﬁes
common variants in three genomic regions,” Nature Genetics,
vol. 39, no. 8, pp. 1000–1006, 2007.
[17] J. Montplasir, A. Nicolas, R. Godbout, and A. Walters, “Rest-
less legs syndrome and periodic limb movement disorder,” in
PrinciplesandPracticeofSleepMedicine,M.H.Kryger ,T .Roth,
and W. C. Dement, Eds., pp. 743–752, Saunders, Philadelphia,
Pa, USA, 3rd edition, 2000.
[18] H. Bastuji and L. Garc´ ıa-Larrea, “Sleep/wake abnormalities
in patients with periodic leg movements during sleep: factor
analysis on data from 24-h ambulatory polygraphy,” Journal of
Sleep Research, vol. 8, no. 3, pp. 217–223, 1999.
[19] J. Carrier, S. Frenette, J. Montplaisir, J. Paquet, C. Drapeau,
and J. Morettini, “Eﬀects of periodic leg movements during
sleep in middle-aged subjects without sleep complaints,”
Movement Disorders, vol. 20, no. 9, pp. 1127–1132, 2005.
[20] E. Sforza, A. Nicolas, G. Lavigne, A. Gosselin, D. Petit, and
J. Montplaisir, “EEG and cardiac activation during periodic
leg movements in sleep: support for a hierarchy of arousal
responses,” Neurology, vol. 52, no. 4, pp. 786–791, 1999.
[21] .K aradeniz,.Ondz e,.Besset,and.B illiar d,“EEGar ousalsand
awakenings in relation with periodic leg movements during
sleep,” Journal of Sleep Research, vol. 9, no. 3, pp. 273–277,
2000.
[22] F. Ferrillo, M. Beelke, P. Canovaro et al., “Changes in cerebral
and autonomic activity heralding periodic limb movements in
sleep,” Sleep Medicine, vol. 5, no. 4, pp. 407–412, 2004.
[23] S. Lavoie, F. De Bilbao, J. Haba-Rubio, V. Ibanez, and E.
Sforza, “Inﬂuence of sleep stage and wakefulness on spectralISRN Endocrinology 5
EEG activity and heart rate variations around periodic leg
movements,” Clinical Neurophysiology, vol. 115, no. 10, pp.
2236–2246, 2004.
[24] L. Parrino, M. Boselli, G. P. Buccino, M. C. Spaggiari, G.
Di Giovanni, and M. G. Terzano, “The cyclic alternating
pattern plays a gate-control on periodic limb movements
during non-rapid eye movement sleep,” Journal of Clinical
Neurophysiology, vol. 13, no. 4, pp. 314–323, 1996.
[25] A. G. Guggisberg, C. W. Hess, and J. Mathis, “The signiﬁcance
of the sympathetic nervous system in the pathophysiology of
periodiclegmovementsinsleep,”Sleep,vol.30,no.6,pp.755–
766, 2007.
[26] M. W. Johns, “A new method for measuring daytime sleepi-
ness: the Epworth sleepiness scale,” Sleep,v o l .1 4 ,n o .6 ,p p .
540–545, 1991.
[ 2 7 ]C .I b e r ,S .A n c o l i - I s r a e l ,A .L .J .C h e s s o n ,a n dS .F .Q u a n ,
For the American Academy of Sleep Medicine: The AASM
Manual for the Scoring of Sleep and Associated Events. Rules,
Terminology and Technical Speciﬁcation, IL ASSM Manual
for Scoring Sleep, American Academy of Sleep Medicine,
Westchester, NY, USA, 2007.
[28] K. Spiegel, R. Leproult, and E. Van Cauter, “Impact of sleep
debt on metabolic and endocrine function,” The Lancet, vol.
354, no. 9188, pp. 1435–1439, 1999.
[29] C. J. Ware, R. Blumoﬀ, and J. T. Pittard, “Peripheral
vasoconstriction in patients with sleep related periodic leg
movements,” Sleep, vol. 11, no. 2, pp. 182–187, 1988.
[ 3 0 ]S .F .B u c h e r ,K .C .S e e l o s ,W .H .O e r t e l ,M .R e i s e r ,a n dC .
Trenkwalder, “Cerebral generators involved in the pathogen-
esis of the restless legs syndrome,” Annals of Neurology, vol. 41,
no. 5, pp. 639–645, 1997.
[31] S. Happ, W. Pirker, G. Kl¨ o s c h ,C .S a u t e r ,a n dJ .Z e i t l h o f e r ,
“Periodic leg movements in patients with Parkinson’s disease
are associated with reduced striatal dopamine transporter
binding,”JournalofNeurology,vol.250,no.1,pp.83–86,2003.
[32] M. Gallego, R. Seti´ e n ,M .J .I z q u i e r d o ,O .C a s i s ,a n dE .
Casis, “Diabetes-induced biochemical changes in central and
peripheral catecholaminergic systems,” Physiological Research,
vol. 52, no. 6, pp. 735–741, 2003.
[33] G. Merlino, P. Dolso, R. Canesin, I. Cancelli, M. Valente, and
G.L.Gigli,“Theacuteeﬀectofalowdosageofpramipexoleon
severe idiopathic restless legs syndrome: an open-label trial,”
Neuropsychobiology, vol. 54, no. 3, pp. 195–200, 2007.